Literature DB >> 9516041

Pharmacokinetic and bioequivalence evaluation of two generic formulations of oral artesunate.

K Na-Bangchang, J Karbwang, K Congpoung, A Thanavibul, R Ubalee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516041     DOI: 10.1007/s002280050397

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.

Authors:  P Newton; Y Suputtamongkol; P Teja-Isavadharm; S Pukrittayakamee; V Navaratnam; I Bates; N White
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Artemisinins.

Authors:  C J Woodrow; R K Haynes; S Krishna
Journal:  Postgrad Med J       Date:  2005-02       Impact factor: 2.401

3.  The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.

Authors:  Paul N Newton; Karen I Barnes; Peter J Smith; Alicia C Evans; Wirongrong Chierakul; Ronatrai Ruangveerayuth; Nicholas J White
Journal:  Eur J Clin Pharmacol       Date:  2006-11-07       Impact factor: 2.953

Review 4.  Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.

Authors:  Carrie A Morris; Stephan Duparc; Isabelle Borghini-Fuhrer; Donald Jung; Chang-Sik Shin; Lawrence Fleckenstein
Journal:  Malar J       Date:  2011-09-13       Impact factor: 2.979

5.  Pharmacokinetics of artesunate after single oral administration to rats.

Authors:  P L Olliaro; N K Nair; K Sathasivam; S M Mansor; V Navaratnam
Journal:  BMC Pharmacol       Date:  2001-12-20

6.  Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults.

Authors:  Siwalee Rattanapunya; Tim R Cressey; Ronnatrai Rueangweerayut; Yardpiroon Tawon; Panida Kongjam; Kesara Na-Bangchang
Journal:  Malar J       Date:  2015-10-09       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.